Primary Sjögren syndrome and inclusion body myositis;Síndrome de Sjögren primária e miosite de corpos de inclusão

Acta Reumatologica Portuguesa

Volumn 34, Issue 2, 2009, Pages 261-265

  Monteiro, Paulo ^a   Coutinho, Margarida ^a   João Salvador, Maria ^a   Malcata, Armando ^a  

^a CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

Author keywords

Immunosuppression; Inclusion body; Myositis; Sj gren syndrome

Indexed keywords

AGED; ARTICLE; CASE REPORT; FEMALE; HUMAN; INCLUSION BODY MYOSITIS; SJOEGREN SYNDROME;

AGED; FEMALE; HUMANS; MYOSITIS, INCLUSION BODY; SJOGREN'S SYNDROME;

EID: 67650123209     PISSN: 0303464X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Yunis EJ, Samaha FJ. Inclusion body myositis. Lab Invest 1971;25:240-248
2. Eisen A, Berry K, Gibson C. Inclusion body myositis: myopathy or neuropathy? Neurology 1983;33:1109-1114
3. Chrisholm DM, Mason DK. Labial salivary gland biopsy in Sjögren syndrome: J Clin Pathol 1968;21: 656-668
4. Catoggio L. Management of inflammatory muscle disease. Rheumatology 2008, 4th ed, 1461-68
5. Alexander EL. Neuromuscular complications of primary Sjögren syndrome. In: Talal N, Moutsopoulos HM, Kassan SS, eds. Sjögren syndrome. Clinical and Immunological Aspects. Berlin: Spinger-Verlag, 1987:61-82
6. Krauss A, Cifuentes M, Villa AR et al. Myositis in primary Sjögren syndrome. Report of 3 cases. J Rheumatol 1994;21:4:649-653
7. Martinez- Lavin M, Vaughan JH, Tan EM. Autoantibodies and the spectrum of Sjögren's syndrome. Ann Intern Med 1979;91:185-190
8. Vrethem M, Lindvall VM, Holmgren H et al. Neuropathy and myopathy in primary Sjögren's syndrome: neurophysiological, immunological and muscle biopsy results. Acta Neurol Scand 1990;82:126-131
9. Alexander EL, Josifek L Provost TT, Alexander GE. Myositis/vasculitis in primary Sjögren's syndrome (abstr). Arthritis Rheum 1982;25:S15
10. Molina R, Provost TT, Arnet FC et al. Primary Sjögren's syndrome in men. Am J Med 1986;80:23-31
11. Layzer RB. Inflammatory and immune disorders. In: Layzer RB, editor. Neuromuscular manifestations of systemic disease. Philadelphia: Davis; 1985:227-228
12. Leroy JP, Drosos AA, Yiannopoulos P, Moutsopoulos HM. Intravenous pulse cyclophosphamide therapy in myositis and Sjögren's syndrome. Arthritis Rheum 1990;33:1579-1581
13. Cohen MR, Sulaiman AR, Garancis JC, Wortmann RL. Clinical heterogeneity and treatment response in inclusion body myositis. Arthritis Rheum 1989;32:734-740
14. Emslie-Smith AM, Arahata K, Engel AG. Major histocompatibility complex class I antigen expression immunolocalization of interferon subtypes and T-cell-mediated cytotoxicity in myopathies. Hum Pathol 1989;20:224-231
15. Oldfors A, Lindberg C. Diagnosis, pathogenesis and treatment of inclusion body myositis. Curr Opin Neurol 2005;18:497-503
16. Amato AA, Gronseth GS. Inclusion body myositis: clinical and pathological boundaries. Ann Neurol 1996; 40:581-586
17. Askanas V, Engel WK. New advances in inclusion body myositis. Curr Opin Rheum 1993;5:753-741
18. Engel AG, Hohlfeld R, Banker BQ. The polymyositis and dermatomyositis syndrome. In: Engel AG. Myology. New York: Mac Graw Hill; 1994: 1335-83
19. Garlepp MJ, Mastaglia FL. Inclusion body myositis. J Neurol Neurosurg Psychiatr 1996;60:251-255
20. Griggs RC, Askanas V, DiMauro S et al. Inclusion body myositis and myopathies. Ann Neurol 1995;38:705-713
21. Derk CT, Vivino FB, Kenyon L, Mandel S. Inclusion body myositis in connective tissue disorders: case report and review of the literature. Clin Rheumatol 2003;22:324-328
22. Chad D, Good P, Adelman L et al. Inclusion body myositis associated with Sjögren's syndrome. Arch Neurol 1982;39:186-188
23. Yood RA, Smith TW. Inclusion body myositis ans systemic lupus erythematosus. J Rheumatol 1985;12:568-570
24. Limaye V, Scott G, Kwiatek R et al. Inclusion body myositis associated with systemic lupus erythematosus. Aust NZ J Med 2000;30:275-276
25. Riggs JE, Schochet SS, Gutmann L et al. Inclusion body myositis and chronic immune thrombocytopenia. Arch Neurol 1984;41:93-95
26. Tome FMS, Fardeau M, Lebon P et al. Inclusion body myositis. Acta Neuropathol 1981; Suppl 7: 287-291
27. Lane RJM, Fulthorpe JJ, Hudgson P. Inclusion body myositis a case with associated collagen vascular disease responding to treatment. J Neurol Neurosurg Psychiatry 1985;48:270-273
28. Danon MJ, Reyes MG, Perwena OH, Masdeu JC, Manaligod JR. Inclusion body myositis. A corticosteroid resistant idiopathic inflammatory myopathy. Arch Neurol 1982;39:760-764
29. Askanas V, King Engel W. Inclusion-body myositis - a myodegenerative conformational disorder associated with A? protein misfolding, and proteasome inhibition. Neurology 2006; Suppl 1:39-48
30. Gea JP, O'Callaghan AS, Valeta JS, Junyent J. Miositis por cuerpos de inclusión y síndrome de Sjögren primario. Med Clin (Barc) 2003;120:317-319
31. Khraishi MM, Jay V, Keystone EC. Inclusion body myositis in association with vitamin B12 deficiency and Sjögren's syndrome. J Rheumatol 1992;19:306-309
32. Kanellopoulos P, Baltoyiannis C, Tzioufas AG. Primary Sjögren's syndrome associated with inclusion body myositis. Rheumatology 2002;41:440-444
33. McCoy AL, Bubb MR, Plotz PH, Davis JC. Inclusion body myositis long after dermatomyositis: a report of two cases. Clin Exp Rheumatol 1999;17:235-239
34. Lindvall B, Bengtsson A, Ernerudh J, Eriksson P. Subclinical myositis is common in primary Sjögren's syndrome and is not related to muscle pain. J Rheumatol 2002;29:717-725
35. Leff RL. Miller FW, Hicks J, Fraser DD, Plotz P. The treatment of inclusion body myositis: a retrospective review and randomized, prospective trial of immunosupressive therapy. Medicine 1989;72:225-235
36. Plotz P, Rider LG, Targoff IN, Raben N, O'Hanlon TP, Miller FW. Myositis: immunologic contributions to understanding cause, pathogenesis and therapy. Ann Intern Med 1995; 122:715-724